142 related articles for article (PubMed ID: 12867629)
1. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions.
Vazirabadi G; Geiger TR; Coffin Iii WF; Martin JM
J Gen Virol; 2003 Aug; 84(Pt 8):1997-2008. PubMed ID: 12867629
[TBL] [Abstract][Full Text] [Related]
2. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
Erickson KD; Martin JM
J Virol; 2000 Jan; 74(2):1057-60. PubMed ID: 10623774
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is down-regulated by lytic LMP-1.
Pandya J; Walling DM
J Virol; 2006 Aug; 80(16):8038-46. PubMed ID: 16873260
[TBL] [Abstract][Full Text] [Related]
4. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
Erickson KD; Martin JM
Virology; 1997 Jul; 234(1):1-13. PubMed ID: 9234942
[TBL] [Abstract][Full Text] [Related]
5. Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.
Erickson KD; Berger C; Coffin WF; Schiff E; Walling DM; Martin JM
J Virol; 2003 Apr; 77(7):4415-22. PubMed ID: 12634399
[TBL] [Abstract][Full Text] [Related]
6. Localization of the Epstein-Barr virus protein LMP 1 to exosomes.
Flanagan J; Middeldorp J; Sculley T
J Gen Virol; 2003 Jul; 84(Pt 7):1871-1879. PubMed ID: 12810882
[TBL] [Abstract][Full Text] [Related]
7. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
8. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
Vrzalikova K; Vockerodt M; Leonard S; Bell A; Wei W; Schrader A; Wright KL; Kube D; Rowe M; Woodman CB; Murray PG
Blood; 2011 Jun; 117(22):5907-17. PubMed ID: 21411757
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
11. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.
Pandya J; Walling DM
J Virol; 2004 Aug; 78(15):8404-10. PubMed ID: 15254213
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
Wang D; Liebowitz D; Wang F; Gregory C; Rickinson A; Larson R; Springer T; Kieff E
J Virol; 1988 Nov; 62(11):4173-84. PubMed ID: 2845129
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
[TBL] [Abstract][Full Text] [Related]
16. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
17. Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.
Masy E; Adriaenssens E; Montpellier C; Crépieux P; Mougel A; Quatannens B; Goormachtigh G; Faumont N; Meggetto F; Auriault C; Groux H; Coll J
J Virol; 2002 Jul; 76(13):6460-72. PubMed ID: 12050358
[TBL] [Abstract][Full Text] [Related]
18. Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro.
Tang Y; Luo C; Cheng A; Lu S; Xu J; Fu T; Gan R
Mol Med Rep; 2014 Aug; 10(2):1117-21. PubMed ID: 24919846
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
20. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
Prince S; Keating S; Fielding C; Brennan P; Floettmann E; Rowe M
J Virol; 2003 Apr; 77(8):5000-7. PubMed ID: 12663807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
